Terada T, Ueda K, Nakanuma Y
Second Department of Pathology, Kanazawa University School of Medicine, Japan.
Virchows Arch A Pathol Anat Histopathol. 1993;422(5):381-8. doi: 10.1007/BF01605457.
Atypical adenomatous hyperplasia (AAH) is a hyperplastic parenchymal nodular change in the cirrhotic liver, in which overt hepatocellular carcinoma (HCC) occasionally arises. AAH is defined as a sizable hepatocellular nodule with a variable degree of hepatocellular atypia not regarded as HCC, and is different from ordinary adenomatous hyperplasia in which hepatocellular atypia is absent. In the present study, we attempted to evaluate carcinogenetic processes and to find histological variables which indicate malignant transformation in AAH, using 49 surgically resected or autopsied nodules. AAH frequently showed morphological heterogeneity. Atypical lesions within AAHs were divisible into the following three categories from overall histopathological appearances: malignant (A), equivocal (B), or non-malignant (C) lesions. Analysis of combination of these three lesions, which were frequently intermixed in a given AAH, suggested that B lesions appear subsequent to C lesions, and A lesions finally appear in AAH nodules. Among the 14 histological variables, enlargement, hyperchromasia and irregular contour of nuclei were found to correlate well with A lesions. Increased nuclear density, iron resistance, reduction of reticulin fibres, clear cell change, sinusoidal dilatation and presence of abnormal arteries were suggestive of A or B lesions. Nuclear deviation toward the sinusoids, acinar and compact arrangements, fatty change and Mallory's hyaline alone were not useful indicators of A or B lesions. These results indicate that AAH is a preneoplastic or borderline lesion in which overt HCC is likely to evolve through several steps. Although a needle liver biopsy is a useful tool for diagnosis of benign, equivocal and malignant hepatocellular nodular lesions, the needle biopsy specimen should be carefully evaluated by considering the morphological heterogeneity of the AAH and a variable combination of 14 histological variables.
非典型腺瘤样增生(AAH)是肝硬化肝脏中的一种增生性实质结节性改变,偶尔会发生明显的肝细胞癌(HCC)。AAH被定义为一个大小可观的肝细胞结节,具有不同程度的肝细胞异型性,但不被视为HCC,它与无肝细胞异型性的普通腺瘤样增生不同。在本研究中,我们试图利用49个手术切除或尸检的结节来评估致癌过程,并寻找表明AAH中恶性转化的组织学变量。AAH常表现出形态学异质性。从整体组织病理学表现来看,AAH内的非典型病变可分为以下三类:恶性(A)、可疑(B)或非恶性(C)病变。对这三种经常在单个AAH中混合出现的病变组合进行分析表明,B病变出现在C病变之后,而A病变最终出现在AAH结节中。在14个组织学变量中,细胞核增大、深染和轮廓不规则与A病变密切相关。核密度增加、耐铁性、网状纤维减少、透明细胞改变、窦状隙扩张和异常动脉的存在提示A或B病变。仅细胞核向窦状隙偏移、腺泡状和致密排列、脂肪变和马洛里透明小体不是A或B病变的有用指标。这些结果表明,AAH是一种癌前或临界病变,明显的HCC可能通过几个步骤发展而来。虽然经皮肝穿刺活检是诊断良性、可疑和恶性肝细胞结节性病变的有用工具,但应通过考虑AAH的形态学异质性和14个组织学变量的不同组合来仔细评估经皮肝穿刺活检标本。